Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience

被引：0
|
作者：
Omarini, C. [1 ]
Medici, G. [1 ]
Guaitoli, G. [1 ]
Iattoni, E. [1 ]
Moscetti, L. [1 ]
Balduzzi, S. [1 ]
Cascinu, S. [1 ]
Piacentini, F. [1 ]
机构：
[1] Univ Modena Policlin, Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw337.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
F55
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Exposure-safety relationship of trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer (MBC)
    Jin, Jin
    Wang, Bei
    Gao, Yuying
    Samant, Meghan
    Li, Chunze
    Song, Chunyan
    Swain, Sandra M.
    Untch, Michael
    Girish, Sandhya
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] A phase 1b study of S-1 combined with trastuzumab emtansine (T-DM1) for HER2 positive metastatic breast cancer
    Kojima, Yasuyuki
    Yoshie, Reiko
    Kawamoto, Hisanori
    Shimo, Arata
    Uejima, Tomoko
    Iwatani, Tsuguo
    Motoyoshi, Ai
    Haku, Ei
    Kanemaki, Yoshihide
    Tsugawa, Koichiro
    ANNALS OF ONCOLOGY, 2018, 29
  • [43] T-DM1 in Chinese patients with Her2-positive metastatic breast cancer: A multi-center, retrospective, real world study.
    Zhang, Ruyan
    Li, Huiping
    Zhang, Pin
    Hao, Chunfang
    Zhao, Wenhui
    Mo, Xueli
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] HER2 missense mutations in breast cancer cells do not alter HER2 internalization or sensitivity to T-DM1
    Akamatsu, Hiroaki
    Mino, Rosa
    Mettlen, Marcel
    Ye, Dan
    Sudhan, Dhivya R.
    Lin, Albert
    Marin, Arnaldo
    Servetto, Alberto
    Lee, Kyung-min
    Chatterjee, Sumanta
    Schmid, Sandra L.
    Arteaga, Carlos L.
    Hanker, Ariella B.
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Trastuzumab emtansine (T-DM1) for HER2-positive advanced breast cancer
    Thibault, C.
    ONCOLOGIE, 2013, 15 (02) : 126 - 127
  • [46] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinksi, Christoph C.
    Steger, Guenther G.
    Preusser, Matthias
    CANCER RESEARCH, 2015, 75
  • [47] Enhanced antitumor efficacy of T-DM1 in combination with pertuzumab in HER2-positive breast cancer models
    Sun, Yuliang
    Dey, Nandini
    Carlson, Jennifer
    Brammer, Melissa
    De, Pradip
    Leyland-Jones, Brian
    CANCER RESEARCH, 2014, 74 (19)
  • [48] Trastuzumab emtansine (T-DM1) for the treatment of HER2-positive breast cancer
    Sliwkowski, Mark X.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [49] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A. S.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Preusser, M.
    Steger, G. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S184 - S184
  • [50] Trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer and brain metastases
    Jacot, W.
    Pons, E.
    Guiu, S.
    Levy, C.
    Frenel, J-S
    Bachelot, T.
    D'Hondt, V.
    Firmin, N.
    Romieu, G.
    Thezenas, S.
    Dalenc, F.
    CANCER RESEARCH, 2016, 76
12345